What is Surgical VLM?

It is the first domestically developed AI specialized for surgery, created by Diliva Corporation. It not only recognizes surgical situations through images but also has a 'brain' capable of inferring the next steps and engaging in dialogue with surgeons.

What is the difference from conventional medical AI?

Unlike traditional AI, which is limited to identifying organs and blood vessels (the 'eyes'), Surgical VLM has advanced situational understanding capabilities that allow it to comprehend surgical procedures and contexts, enabling it to engage in dialogue.

When will it be put into practical use?

It aims to start commercialization (service provision) by 2026, and is currently undergoing comprehensive preparation and validation tests for other areas.

AI News NQ Analysis

Development of Surgery-Specific Generative AI Bringing a 'Brain' to the Operating Room — Successful Demonstration in Surgery, Full-scale Launch Toward Commercialization

NQ Score 86/100

N1 Content Completeness 8

AI Summary (NQ-processed)

Direava Inc. has developed Japan's first surgery-specific generative AI, 'Surgical VLM', capable of understanding real-time surgical contexts and interacting with doctors. Proven successful at Keio University Hospital, it aims for commercialization in 2026 to support medical education and improve quality.

AI Analysis

Frequently Asked Questions

Q: What is Surgical VLM?: A: It is the first domestically developed AI specialized for surgery, created by Diliva Corporation. It not only recognizes surgical situations through images but also has a 'brain' capable of inferring the next steps and engaging in dialogue with surgeons.
Q: What is the difference from conventional medical AI?: A: Unlike traditional AI, which is limited to identifying organs and blood vessels (the 'eyes'), Surgical VLM has advanced situational understanding capabilities that allow it to comprehend surgical procedures and contexts, enabling it to engage in dialogue.
Q: When will it be put into practical use?: A: It aims to start commercialization (service provision) by 2026, and is currently undergoing comprehensive preparation and validation tests for other areas.